1-6 of 6
Authors: Leonardo Salese
Save search
Sort by
Journal Article

Assessment of Safety and Efficacy of Tofacitinib, Stratified by Age, in Patients from the Ulcerative Colitis Clinical Program Open Access

PDF
Gary R Lichtenstein and others
Inflammatory Bowel Diseases, Volume 29, Issue 1, January 2023, Pages 27–41, https://doi.org/10.1093/ibd/izac084
Published: 07 November 2022
Journal Article

Clostridium difficile Infection in Patients with Ulcerative Colitis Treated with Tofacitinib in the Ulcerative Colitis Program Open Access

PDF
Edward V Loftus and others
Inflammatory Bowel Diseases, Volume 29, Issue 5, May 2023, Pages 744–751, https://doi.org/10.1093/ibd/izac139
Published: 06 July 2022
Journal Article

Lipid Profiles in Patients With Ulcerative Colitis Receiving Tofacitinib—Implications for Cardiovascular Risk and Patient Management Open Access

PDF
Bruce E Sands and others
Inflammatory Bowel Diseases, Volume 27, Issue 6, June 2021, Pages 797–808, https://doi.org/10.1093/ibd/izaa227
Published: 01 September 2020
Journal Article

Tofacitinib in Patients with Ulcerative Colitis: Inflammatory Bowel Disease Questionnaire Items in Phase 3 Randomized Controlled Induction Studies Open Access

PDF
Marla C Dubinsky and others
Inflammatory Bowel Diseases, Volume 27, Issue 7, July 2021, Pages 983–993, https://doi.org/10.1093/ibd/izaa193
Published: 14 August 2020
Journal Article

Real-world Effectiveness of Advanced Therapies Among Patients With Moderate to Severe Ulcerative Colitis in the United States Open Access

PDF
Millie D Long and others
Inflammatory Bowel Diseases, Volume 26, Issue 6, June 2020, Pages 941–948, https://doi.org/10.1093/ibd/izz204
Published: 27 September 2019
Journal Article

P025 PERCEIVED DISEASE CONTROL AND TREATMENT SATISFACTION AMONG PATIENTS WITH ULCERATIVE COLITIS IN THE UNITED STATES Get access

PDF
Martine Maculaitis and others
Inflammatory Bowel Diseases, Volume 25, Issue Supplement_1, February 2019, Page S13, https://doi.org/10.1093/ibd/izy393.029
Published: 07 February 2019